SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001558370-22-010650
Filing Date
2022-07-12
Accepted
2022-07-12 17:10:50
Documents
13
Period of Report
2022-07-08
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A kala-20220708x8ka.htm   iXBRL 8-K/A 38738
2 EX-99.1 kala-20220708xex99d1.htm EX-99.1 393689
  Complete submission text file 0001558370-22-010650.txt   574885

Data Files

Seq Description Document Type Size
3 EX-101.SCH kala-20220708.xsd EX-101.SCH 3132
4 EX-101.LAB kala-20220708_lab.xml EX-101.LAB 15924
5 EX-101.PRE kala-20220708_pre.xml EX-101.PRE 10059
7 EXTRACTED XBRL INSTANCE DOCUMENT kala-20220708x8ka_htm.xml XML 4824
Mailing Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476
Business Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476 781-996-5252
Kala Pharmaceuticals, Inc. (Filer) CIK: 0001479419 (see all company filings)

IRS No.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-38150 | Film No.: 221079678
SIC: 2834 Pharmaceutical Preparations